Come meet us and hear our pitch at The China-Israel Investment Summit, which is the premiere facilitator of cross border collaboration between Israel and China. During the event, prominent Chinese investors are paired with innovative Israeli companies from a variety of industry sectors in an effort to forge new business relationships and facilitate investments....see you soon in Hong Kong (25-26/6) and Zhuhai (27-28/6).
We are proud to announce our selection as a 2017 TechConnect Innovation Awardee.
The TechConnect Innovation Awards selects the top early-stage innovations from around the world through an industry-review process of the top 20% of annually submitted technologies into the TechConnect National Innovation Summit. Rankings are based on the potential positive impact the submitted technology will have on a specific industry sector.
The TechConnect World Innovation Conference is an annual event uniquely designed to accelerate the commercialization of innovations out of the lab and into industry.
Washington DC, May 14-17...see you soon.
Come hear our CEO pitch at the JLM-BIOCITY Pharma Startup Pitch Evening. Thursday, April 20th, 2017.
JLM-BioCity and the investors chose 5 startups from 13 companies that submitted, to pitch to a panel of leading pharma investors.
Come say hello to us and cheer for us at the
biggest international startup competition in China which is coming to Israel on March 16th!
We were chosen as one of the 4 Israeli selected startups from in the biotech/pharma/life-science sector.
Come say hello to us at the "Innovations in Gastroenterology, 2017 Symposium” to be held in Tel Aviv, January 4-6, 2017, Israel.
This is an exclusive event where gastroenterologists, researchers, and the pharmaceutical industry from all over the world meet and learn about novel emerging technologies as well as practical gastroenterology and hepatology.
We presented an abstract about our IBD drug (press Read More and see abstract #11).
Come say hello to us and hear our presentation at the FIGHTING IBD Conference, September 7th, 2016, Bar Ilan University, Ramat Gan, Israel. The Israeli Foundation for Crohn's Disease and Ulcerative Colitis (CCFI) is organizing the First Interdisciplinary Global High-Tech & Innovation Gabfest (FIGHTING) IBD.
The FIGHTING IBD conference is comprised of three sessions: IBD focused startups, commercially applicable IBD related medical R&D, and IBD Financing. In addition, there are two keynote lectures by two distinguished guests, Prof. Julian Panes from Barcelona, president of ECCO, and Dr. Marco Greco from Milano, President of the European Patients' Forum, which integrates more than 60 European patient associations, including EFCCA.
We presented at the15th IATI-BIOMED 2016 Conference and Exhibition, May 24-26, 2016, Tel-Aviv, Israel
We are pleased to announce that Concenter BioPharma has been chosen to take part in the Start-up Area on the 1st Day May, 24, as part of the IATI Biomed 2016 Conference that will take place in the David InterContinental Hotel, Tel Aviv on May 24-26, 2016.
Each company has been carefully selected by the IATI professional committee to be part of the conference.
Our CEO attended the NewYorkBIO 2016 Annual Conference May 11-12, 2016. The NewYorkBIO Annual Conference is one of the largest life science business conferences, in the US, drawing hundreds of attendees from across the Northeast and far beyond.
Each year the NewYorkBIO Annual Conference provides a forum where emerging companies, established players, academic investigators, institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future of New York's biotechnology industry.
We attended The World Orphan Drug Congress (Washington DC, USA) 20-22 April 2016.
World Orphan Drug Congress USA 2016 was the benchmark for doing business when it comes to technology and innovation.
With keynotes, interactive discussions, workshops and roundtables, this event is designed to tackle the most important challenges facing the orphan drug and rare disease industry.
We attended and spoke at - Biovision World Life Science Forum (Lyon, France) 13-14 April 2016.
Biovision World Life Science Forum fostering a unique approach to meet,connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors.
Biovision 2016 pattern is dedicated to strengthen Action & Interaction for Innovation with:
Prospective part with a main theme on "Global health and Prevention" and specific paths (Medecine & Humanities, Vaccines, Cancer Prevention and Digitalized Patients) with workshops , plenary sessions and calls for action.
Catalyzer & Investors parts with reinforced and segmented sourcing; allowing more specific expertise for the evaluation and the follow up of the projects including financing.
We attended and spoke at the Biotech Showcase - January 12th, 09:15 Davidson (4th Floor)
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences...
We sponsored and our CEO spoke at the World Orphan Drug Congress (Geneva)
The World Orphan Drug Congress will be going into its 6th year in November 2015. The Congress was one of the first events to bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers...
We had a great time at the Orphan Drugs Summit 2015 (Copenhagen)
With payers, hospital representatives, patient organisations, venture capitalists, regulatory bodies, drug developers, researchers and industry associations joining us the whole orphan drugs ecosystem was represented at the 5th Annual Orphan Drugs Summit!